BLACK WEEKSFlacoane −15% · kituri −10% · restul −5%cu codulLivrare gratuită în Germania de la 200 €

Această pagină a fost tradusă automat și poate conține erori. Sunteți vorbitor nativ? Ne bucurăm să primim feedbackul și corecturile dumneavoastră.Trimiteți feedback

The Peptide Desk The Peptide Desk
PT-141 Nasal, fotografie produs
Sexual Health

PT-141 Nasal

Sexual Health

  • Livrare din Germania

Comandă

Preț unitar - Livrare gratuită în Germania de la 200 € în timpul Black Weeks
  • DHL cu urmărire
  • Ambalare discretă

4.6 din 5 pe Trustpilot73 recenzii

Căutat și ca: PT-141 Nasenspray

Pe scurt

PT-141 Nasal în cifre

Valorile principale din lexiconul nostru. Trageți punctul de-a lungul curbei pentru a vedea cât rămâne, prin calcul, după o doză.

Articolul complet din lexicon

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2 hours

Half-life ~2 hours
After 4 hours: 25 %
Hour 250 %Hour 425 %Hour 612.5 %Hour 103.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

About2hours

after nasal dosing (1.9 to 2.1 hours), peak levels at around 30 minutes

Class
Non-selective melanocortin agonistmainly MC4R and MC1R, plus MC3R, cyclic heptapeptide, medical name: bremelanotide
Frequency
No more than once in 24 hours and no more than 8 uses per month (the label rule for the injection)
Form
Ready-made nasal spray, 10mg in 5.4ml1.85mg/ml, about 185mcg per spray, about 50 sprays
Sizes
10 mg1 size in the shop

Pentru PT-141 Nasal nu există încă o analiză de laborator. Votați pentru elTestați-l singur, noi plătim jumătateToate analizele de laborator

Informații

Totul despre PT-141 Nasal

Informații detaliate în curând.

Dozare

Se încarcă informațiile de dozare …

Mai multe în lexicon

FAQ

Întrebări frecvente

Surse pentru fiecare răspuns: articolul din lexicon

Mai aveți o întrebare?

Scrieți-ne, echipa noastră vă ajută.

Is PT-141 approved?

Yes, as bremelanotide in the USA since 2019. The approval is narrow: women before menopause with acquired, generalised low sexual desire that causes distress. Not for men, not after menopause and according to the label not to enhance sexual performance.

How does PT-141 differ from PDE-5 inhibitors?

The point of action. PDE-5 inhibitors act via blood flow. Bremelanotide activates melanocortin receptors, including MC4R on nerve cells in the brain. How this leads to more desire is not clear according to the label.

What did the phase 3 trials show?

In two trials with 1,267 women in total, desire rose by 0.35 points more than on placebo after 24 weeks and distress fell by 0.33 points more. Both were statistically significant. In the open extension over 52 weeks the values stayed stable.

How long does PT-141 stay in the body?

After one dose under the skin the level peaks after about one hour, the half-life is about 2.7 hours. That fits use on demand, as the entry describes.

Which side effects were seen?

Most often nausea (40 percent versus 1.3 percent on placebo), facial flushing (20 percent) and headache (11 percent). Nausea was the most common reason for stopping. Blood pressure rose by a few mmHg for a short time after a dose.

What about dark patches on the skin?

Via MC1R bremelanotide stimulates pigment formation. Patchy darkening, including on the face and gums, was rare with dosing according to the label (about 1 percent). After up to 16 doses on consecutive days it occurred in more than a third and did not resolve in everyone.

Produse asemănătoare

Produse similare